384 related articles for article (PubMed ID: 20398667)
1. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer.
Lee HJ; Nam KT; Park HS; Kim MA; Lafleur BJ; Aburatani H; Yang HK; Kim WH; Goldenring JR
Gastroenterology; 2010 Jul; 139(1):213-25.e3. PubMed ID: 20398667
[TBL] [Abstract][Full Text] [Related]
2. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer.
Suh YS; Lee HJ; Jung EJ; Kim MA; Nam KT; Goldenring JR; Yang HK; Kim WH
Ann Surg Oncol; 2012 Apr; 19(4):1240-9. PubMed ID: 22048633
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia.
Lee SH; Jang B; Min J; Contreras-Panta EW; Presentation KS; Delgado AG; Piazuelo MB; Choi E; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2022; 13(1):199-217. PubMed ID: 34455107
[TBL] [Abstract][Full Text] [Related]
5. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
7. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
9. Mucins, trefoil factors and pancreatic duodenal homeobox 1 expression in spasmolytic polypeptide expressing metaplasia and intestinal metaplasia adjacent to gastric carcinomas.
Can N; Oz Puyan F; Altaner S; Ozyilmaz F; Tokuc B; Pehlivanoglu Z; Kutlu KA
Arch Med Sci; 2020; 16(6):1402-1410. PubMed ID: 33224340
[TBL] [Abstract][Full Text] [Related]
10. Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach.
Weis VG; Petersen CP; Mills JC; Tuma PL; Whitehead RH; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(8):G777-92. PubMed ID: 25190476
[TBL] [Abstract][Full Text] [Related]
11. Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland.
Halldórsdóttir AM; Sigurdardóttrir M; Jónasson JG; Oddsdóttir M; Magnússon J; Lee JR; Goldenring JR
Dig Dis Sci; 2003 Mar; 48(3):431-41. PubMed ID: 12757153
[TBL] [Abstract][Full Text] [Related]
12. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
13. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach.
Sousa JF; Nam KT; Petersen CP; Lee HJ; Yang HK; Kim WH; Goldenring JR
Gut; 2016 Jun; 65(6):914-24. PubMed ID: 25800782
[TBL] [Abstract][Full Text] [Related]
14. Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer.
Goldenring JR
J Pathol; 2023 Jun; 260(2):109-111. PubMed ID: 37145865
[TBL] [Abstract][Full Text] [Related]
15. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.
Nomura S; Baxter T; Yamaguchi H; Leys C; Vartapetian AB; Fox JG; Lee JR; Wang TC; Goldenring JR
Gastroenterology; 2004 Aug; 127(2):582-94. PubMed ID: 15300590
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.
Sousa JF; Ham AJ; Whitwell C; Nam KT; Lee HJ; Yang HK; Kim WH; Zhang B; Li M; LaFleur B; Liebler DC; Goldenring JR
Am J Pathol; 2012 Nov; 181(5):1560-72. PubMed ID: 22944598
[TBL] [Abstract][Full Text] [Related]
17. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
18. Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer.
Choi B; Lee HJ; Min J; Choe HN; Choi YS; Son YG; Ahn HS; Suh YS; Goldenring JR; Yang HK
Cancer Biomark; 2017 Jul; 19(3):231-239. PubMed ID: 28453457
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
20. Oxyntic atrophy, metaplasia, and gastric cancer.
Goldenring JR; Nam KT
Prog Mol Biol Transl Sci; 2010; 96():117-31. PubMed ID: 21075342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
